I doubt if such info sent the stock down 14%. I'm guessing it was the proverbial baby/bath water with a major holder or fund dump, particularly given that several other small bios dropped quite a bit, or there was a leak within the company or FDA about bad news related to m-copaxone.
We should receive clarity on Monday during the presentation as far as any negative FDA issues.
Market Data 
Markets 
AI
